Cover Image

RSV Disease Burden in Older Adults: An Italian Multiregion Pilot Study of Acute Respiratory Infections in Primary Care Setting, Winter Season 2022–2023

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Sara Bracaloni, Enrica Esposito, Michela Scarpaci, Tommaso Cosci, Beatrice Casini, Federica Chiovelli, Guglielmo Arzilli, Mauro Pistello, Donatella Panatto, Matilde Ogliastro, Daniela Loconsole, Maria Chironna, Caterina Rizzo
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Influenza and Other Respiratory Viruses
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RSV Disease Burden in Primary Care in Italy: A Multi‐Region Pediatric Study, Winter Season 2022–2023
by: Michela Scarpaci, et al.
Published: (2024)

Economic Impact of Respiratory Syncytial Virus Infections in Children Under 5 Years of Age Attending Primary Care in Italy: A Prospective Cohort Study in Two Regions
by: Valérie D. V. Sankatsing, et al.
Published: (2025)

Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season
by: Daniel Aguilar Figueroa, et al.
Published: (2025)

Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review
by: Richard Osei‐Yeboah, et al.
Published: (2024)

Impact of Nirsevimab on RSV and Non‐RSV Severe Respiratory Infections in Hospitalized Infants
by: María Luz García‐García, et al.
Published: (2025)

Comparison of the Burden and Temporal Pattern of Hospitalisations Associated With Respiratory Syncytial Virus (RSV) Before and After COVID‐19 in New Zealand
by: Nikki Turner, et al.
Published: (2024)

Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review
by: Susanne Heemskerk, et al.
Published: (2024)

Evaluating the Impact of Different Methods on the Timing and Duration of RSV Epidemics: Analysis of Surveillance Data From the GERi (Global Epidemiology of RSV in Hospitalized and Community Care) Study
by: Lisa Staadegaard, et al.
Published: (2025)

Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV
by: Atsuko Yamamoto, et al.
Published: (2024)

Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK
by: Joanna Waldock, et al.
Published: (2024)

Human Metapneumovirus Circulation and Seasonality on a Global Scale, 2016–2025: Changes in Patterns and Epidemic Timing in the Pre‐ Versus Post‐COVID‐19 Era
by: Enrica Castellana, et al.
Published: (2025)

Assessing the Impact of Non‐Pharmaceutical Interventions During the COVID‐19 Pandemic on RSV Seasonality in Europe
by: Susanne Heemskerk, et al.
Published: (2025)

An Improved Rapid and Sensitive Long Amplicon Method for Nanopore‐Based RSV Whole‐Genome Sequencing
by: Xiaomin Dong, et al.
Published: (2025)

Correction to “Assessing the Impact of Non‐Pharmaceutical Interventions During the COVID‐19 Pandemic on RSV Seasonality in Europe”
Published: (2025)

Bridging Genomics and Clinical Medicine: RSVrecon Enhances RSV Surveillance With Automated Genotyping and Clinically Important Mutation Reporting
by: Lei Li, et al.
Published: (2026)

Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)]
by: G. Sever Yildiz, et al.
Published: (2024)

Introducing the Concept of Small Vulnerable Newborns (SVN) as an Additional Endpoint to Evaluate Birth Outcomes in the Context of RSV Immunization Studies—A Commentary
by: Jacob Gerstenberg, et al.
Published: (2026)

Correction to: The Respiratory Syncytial Virus Prefusion F Protein Vaccine Attenuates the Severity of RSV‐Associated Disease in Breakthrough Infections in Adults ≥60 Years of Age
Published: (2024)

Nirsevimab Effectiveness Against RSV‐Related Hospitalisations in Children Under 24 Months: A Test‐Negative Case–Control Study in Portugal, 2024–2025
by: Vânia Gaio, et al.
Published: (2025)

Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study
by: Haruka Maeda, et al.
Published: (2026)

The Potential for Twice‐Annual Influenza Vaccination to Reduce Disease Burden
by: Shuyi Zhong, et al.
Published: (2025)

Changing Epidemiological Pattern and Higher Disease Burden of Influenza in China, 2022 to 2025
by: Hairu Yu, et al.
Published: (2025)

A Randomized, Double‐Blind, Placebo‐Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF‐Based Regimen in Japanese Adults Aged 60 Years and Older
by: Takashi Eto, et al.
Published: (2024)

Estimating the Undetected Burden of Respiratory Syncytial Virus Hospitalizations in Adults Through Capture–Recapture Methods
by: Amanda C. Howa, et al.
Published: (2024)

Economic Burden of Respiratory Viruses in Latin America and the Caribbean (LAC): A Scoping Literature Review
by: Nelson J. Alvis‐Zakzuk, et al.
Published: (2025)

Burden of Influenza and Cost‐Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India
by: Anand Krishnan, et al.
Published: (2026)

The Burden of Respiratory Syncytial Virus in Children With Acute Otitis Media: A Systematic Review and Meta‐Analysis
by: Sebastien Kenmoe, et al.
Published: (2026)

Correction to “Population‐Based Hospitalization Burden Estimates for Respiratory Viruses, 2015–2019. Influenza Other Respir Viruses”
Published: (2025)

The National Burden of Influenza‐Associated Respiratory Illness Among Children Aged <5 Years in Niger, 2015–2018
by: Adamou Lagare, et al.
Published: (2025)

The Burden of Seasonal Influenza and Its Potential Complications Among Older Japanese Adults: A Real‐World Database Study
by: Takeshi Arashiro, et al.
Published: (2024)

Economic Burden of Medically Attended Respiratory Syncytial Virus Infections Among Privately Insured Children Under 5 Years of Age in the USA
by: Phuong T. Tran, et al.
Published: (2024)

Incidence of Respiratory Syncytial Virus Infection Among Patients Aged Less Than 2 Years: A Retrospective Study From an Italian Southern Region in Years 2018–2023
by: Giuseppe Di Martino, et al.
Published: (2026)

Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain
by: Matilde Zornoza Moreno, et al.
Published: (2024)

Global Epidemiology of Human Adenoviruses, 2016–2024: A Pre‐ and Post‐COVID‐19 Analysis of Circulation Patterns and Epidemic Timing
by: Emma Papini, et al.
Published: (2026)

Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania
by: Lydia M. Mendoza, et al.
Published: (2025)

Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice
by: Sijing Yan, et al.
Published: (2025)

Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024
by: Liliana Antunes, et al.
Published: (2025)

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
by: Lore Merdrignac, et al.
Published: (2024)

Neurologic Complications of Influenza and Potential Protective Vaccine Effects
by: Ann R. Falsey
Published: (2025)

Age‐Related Asymptomatic Rhinovirus Infections Contribute to the Sustained Prevalence in Adults and Are Not Mitigated by Nonpharmaceutical Interventions
by: Dong Wei, et al.
Published: (2026)